SOX2 in Squamous Cell Carcinoma: Amplifying a Pleiotropic Oncogene Along Carcinogenesis

Cell Cycle - United States
doi 10.4161/cc.9.8.11203
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

SOX2 Is an Oncogene Activated by Recurrent 3q26.3 Amplifications in Human Lung Squamous Cell Carcinomas

PLoS ONE
Multidisciplinary
2010English

SOX2 Antagonizes WWC1 to Drive YAP1 Activation in Esophageal Squamous Cell Carcinoma

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

SOX2 Activation Predicts Prognosis in Patients With Head and Neck Squamous Cell Carcinoma

Scientific Reports
Multidisciplinary
2018English

Prognostic Significance of PIK3CA and SOX2 in Asian Patients With Lung Squamous Cell Carcinoma

International Journal of Oncology
Cancer ResearchOncology
2014English

miR‑543 Acts as a Novel Oncogene in Oral Squamous Cell Carcinoma by Targeting CYP3A5

Oncology Reports
MedicineCancer ResearchOncology
2019English

The Set Gene Is a Potential Oncogene in Human Colorectal Adenocarcinoma and Oral Squamous Cell Carcinoma

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2011English

Role of Ubiquitin-Specific Peptidase 22 in Carcinogenesis of Human Pharyngeal Squamous Cell Carcinoma

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2014English

miR-181a Decelerates Proliferation in Cutaneous Squamous Cell Carcinoma by Targeting the Proto-Oncogene KRAS

PLoS ONE
Multidisciplinary
2017English

SOX2 Is the Determining Oncogenic Switch in Promoting Lung Squamous Cell Carcinoma From Different Cells of Origin

Cancer Cell
Cancer ResearchOncologyCell Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy